Literature DB >> 23407925

Efficacy of adalimumab for the treatment of refractory paediatric acrodermatitis continua of hallopeau.

Valentina Dini1, Sabrina Barbanera, Marco Romanelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23407925     DOI： 10.2340/00015555-1540

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  5 in total

1.  Successful treatment of Acrodermatitis continua of Hallopeau associated with psoriatic arthritis with adalimumab.

Authors:  Salima Lefkir; Samy Slimani; Nadjia Brahimi; Aicha Ladjouze-Rezig
Journal:  Eur J Rheumatol       Date:  2015-03-31

Review 2.  Psoriasis in Children and Adolescents: Diagnosis, Management and Comorbidities.

Authors:  I M G J Bronckers; A S Paller; M J van Geel; P C M van de Kerkhof; M M B Seyger
Journal:  Paediatr Drugs       Date:  2015-10       Impact factor: 3.022

Review 3.  Systemic Treatment of Pediatric Psoriasis: A Review.

Authors:  Maddalena Napolitano; Matteo Megna; Anna Balato; Fabio Ayala; Serena Lembo; Alessia Villani; Nicola Balato
Journal:  Dermatol Ther (Heidelb)       Date:  2016-04-16

4.  Outcomes of various types of therapy in patients with treatment-resistant acrodermatitis continua of Hallopeau.

Authors:  L M Smirnova; E Yu Vertieva; O Yu Olisova; E M Anpilogova
Journal:  Biologics       Date:  2019-05-20

Review 5.  The Central Role of Anti-IL-1 Blockade in the Treatment of Monogenic and Multi-Factorial Autoinflammatory Diseases.

Authors:  Silvia Federici; Alberto Martini; Marco Gattorno
Journal:  Front Immunol       Date:  2013-10-31       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.